Latest Articles

Subject

Editorial
Targeting “bad” B cells in multiple sclerosisCould laquinimod be part of the armamentarium?
Thomas G. Forsthuber, Olaf Stuve

September 21, 2016
Views & Reviews
Restoring immune tolerance in neuromyelitis opticaPart I
Larry Steinman, Amit Bar-Or, Jacinta M. Behne, et al.

September 07, 2016
Views & Reviews
Restoring immune tolerance in neuromyelitis opticaPart II
Amit Bar-Or, Larry Steinman, Jacinta M. Behne, et al.

September 07, 2016
Views & Reviews
The topographical model of multiple sclerosisA dynamic visualization of disease course
Stephen C. Krieger, Karin Cook, Scott De Nino, et al.

September 07, 2016
Article
Neuroleptic intolerance in patients with anti-NMDAR encephalitis
Florian Lejuste, Laure Thomas, Géraldine Picard, et al.

August 29, 2016
Clinical/Scientific Notes
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
Moogeh Baharnoori, Jennifer Lyons, Akram Dastagir, et al.

August 23, 2016
Article
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
Keren Regev, Anu Paul, Brian Healy, et al.

August 23, 2016
Article
Distinct T cell signatures define subsets of patients with multiple sclerosis
Mark C. Johnson, Emily R. Pierson, Andrew J. Spieker, et al.

August 23, 2016
Clinical/Scientific Notes
Lymphopenia in treatment-naive relapsing multiple sclerosis
Zhi Wei Lim, Elliot Elwood, Hammad Naveed, et al.

August 12, 2016
Editor's Corner
Complex relationships
Josep Dalmau

August 04, 2016

Pages